Biocan Novel Pi L4, Lyophilisate and solvent for suspension for injection
Biocan Novel Pi L4, Lyophilisate and solvent for suspension for injection
Pooblaščeno
- Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1090, Inactivated
- Leptospira interrogans, serogroup Australis, serovar Bratislava, Inactivated
- Leptospira kirschneri, Serogroup Grippotyphosa, Inactivated
Identifikacija zdravila
Ime zdravila:
Biocan Novel Pi L4, Lyophilisate and solvent for suspension for injection
Biocan Novel Pi/L4 vakcina A.U.V.
Pot uporabe:
-
Subkutana uporaba
Podatki o zdravilu
Učinkovina / Jakost:
-
Na voljo samo v English5.10log10 tissue culture infective dose 501.00Dose
-
Na voljo samo v English51.00Antibody microagglutination-lytic reaction1.00Dose
-
Na voljo samo v English51.00Antibody microagglutination-lytic reaction1.00Dose
-
Na voljo samo v English51.00Antibody microagglutination-lytic reaction1.00Dose
-
Na voljo samo v English40.00Antibody microagglutination-lytic reaction1.00Dose
Farmacevtska oblika:
-
Liofilizat in vehikel za suspenzijo za injiciranje
Withdrawal period by route of administration:
-
Subkutana uporaba
- Dog
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
- QI07AI08
Pravni status za dobavo / izdajo zdravila:
-
Zdravilo, ki se izdaja na veterinarski recept
Status dovoljenja:
-
Valid
Dodatne informacije
Imetnik dovoljenja za promet z zdravilom:
- Bioveta a.s.
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
- Bioveta a.s.
Pristojni organ:
- European Medicines Agency
Številka dovoljenja :
- 3571/X/14 NÉBIH ÁTI
Datum spremembe statusa dovoljenja:
Številka postopka:
- CZ/V/0123/001
Zadevne države članice:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Kako koristna je bila ta stran?: